Company Email Format Management

Mediar Therapeutics

Biotechnology Research 20 Overland St 52 employees

Employees: 52
Contacts: 4
Emails: 4
Phones: 2

mediartx.com LinkedIn Crunchbase

Mediar Therapeutics Overview

Headquarters: 20 Overland St
Website: mediartx.com
Industry: Biotechnology Research
Employees: 52
Founded: 2019
Funding: 85.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

to patients. Here's to your continued success and the lives your work will touch!

About Mediar Therapeutics

Mediar Therapeutics is pioneering a new approach to fibrosis treatment that aims to halt the disease at a different source – the myofibroblast, the key pathogenic cell in fibrosis that drives scarring, disease progression, and ultimately organ failure. Mediar was founded based on a deep understanding of the complex science underlying fibrosis progression. By combining novel targets with reliable, easily detectable blood biomarkers and familiar modalities, Mediar’s goal is to bring forward novel anti-fibrotic therapies that potentially have a precision medicine approach. For more information, contact info@mediartx.com

Mediar Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Mediar Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Daniel Beal, Rn, Bsn, Mba	Director, Clinical Program Lead at Mediar Therapeutics - Mba, Clinical Research Project Management Professional	Greater Chicago Area, United States	Email
Stephanie Moine	Clinical Trial Management - Site Management - Protocol and Clinical Document Development - Site Selection, Initiation, Monitoring, and Close-out	United States	Email Phone
Michael Baran	Partner - Pfizer Ventures	New York City Metropolitan Area, United States	Email Phone
Quinn Parks	Director of Clinical Supply Chain at Mediar Therapeutics	Upton, Massachusetts, United States	Email